Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Stan Baker
On March 2, 2015, California’s Senator Feinstein reintroduced a bill first submitted in 2013 titled 'Preventing Antibiotic Resistance Act of 2015'. In just nine double-spaced pages the bill, if enacted in its current form, will drastically change how antibiotics are developed and used in production animals in the US. Dr Stan Baker, a lawyer with Husch-Blackwell, investigates the impact of the legislation.
With respect to keeping 'chatter' about animal health investment alive, Zoetis is the gift that keeps on giving.
Last week, Kansas City hosted the Animal Health Corridor Investment Forum. This is the first Forum following the explosive emergence of animal health as a Wall Street phenomenon.
Three words: 'Veterinary pharmaceutical compounding'. Undoubtedly these words would likely increase the blood pressure of some Animal Pharm readers.
Initial public offerings (IPOs) are all the rage in the animal health industry because they are new, sexy, and unknown, much like a beautiful stranger you might meet at a cafe in Paris. And just as with the stranger in Paris, the infatuation investors have for animal health could lead to happiness or it could lead to disaster.
Why does the veterinary products industry need dedicated lawyers? Husch Blackwell's Stan Baker explains his role within the US law firm as part of the animal health team.